推荐应用
The RAM34 antibody reacts with the CD34 glycoprotein on the surface of three independently derived mouse CD34-transfected cell lines. RAM34 antibody also reacts with the mouse cell lines PA6, 416B, Swiss 3T6, NIH, 3T3, DA1, and M1, all of which are positive for expression of mouse CD34 mRNA. Cell lines shown to be negative for CD34 transcript, including WEHI-3B, EL4, 18.8, and CMT64/61, are also negative for surface expression of CD34 as determined by RAM34 staining. Normal thymocytes and splenocytes are negative for CD34 expression. In the bone marrow, 7-10% of cells are stained with RAM34 mAb, including most of the Ly-6A/E (Sca-1)+ CD90 (Thy-1)low Lineage Marker- hematopoietic stem cell-enriched subpopulation and myeloerythroid progenitors. CD34 is also expressed on a small percentage of fetal liver cells, including NK-cell progenitors. CD34 has been reported to be expressed on the endothelium of capillaries and, in this form, to function as a ligand for L-selectin. Consistent with this observation, RAM34 antibody stains endothelial cells in spleen, thymus, and postcapillary HEVs in the lymph nodes. It is reported that RAM34 antibody can be used to select CD34+ CD117 (c-Kit)+ Ly-6A/E (Sca-1)+ Lineage Marker- bone marrow-derived hematopoietic stem cells, capable of short-term multi-lineage reconstitution of lethally irradiated mice; while the CD34- CD117+ Sca-1+ Lineage Marker- population contains self-renewing hematopoietic stem cells. Similarly, the bone marrow population with high dye-efflux capacity and which is highly enriched for long-term reconstituting hematopoietic stem cells is CD34- CD117 (c-Kit)+ Ly-6A/E (Sca-1)+ Lineage Marker-.
推荐稀释比 FC:5μL per test for million cells or whole blood in 100 μL volume.

Flow Cytometry analysis of C57BL/6 murine splenocytes stained with CD34 antibody (PE).Rat IgG2a Isotype Control PE (empty blackhistogram).
-25 ~ -15℃保存,收到货之后有效期1年,避免反复冻融。
【应用案例】细胞内蛋白流式细胞术protocol(甲醇方法)
475
2026-05-07
【选购指南】类器官研究之构建与起始细胞鉴定抗体推荐
285
2026-07-21
【选购指南】类器官研究之功能成熟度评估抗体推荐
259
2026-07-21
【应用方向】趋化因子信号传导通路——身体“信号导航”解析
271
2026-07-21
【选购指南】重度抑郁症(MDD)通路研究抗体推荐
233
2026-07-21
【选购指南】帕金森病(PD)代谢机制核心抗体研究指南
272
2026-07-21
【应用方向】抗体助力心脏免疫研究——解锁心衰防治新方向
226
2026-07-21
【应用方向】抗体助力心肌肥大与心衰研究:从基础探索到科研应用
257
2026-07-21
【应用方向】抗体助力癌症代谢通路研究——肿瘤代谢科普与研究工具指南
256
2026-07-21
【应用方向】抗体应用研究——心肌纤维化解析
20364
2026-04-14
【技术讲解】抗体赋能心肌梗死研究—精准靶向,助力科研突破
7330
2026-04-14
【应用方向】胚胎干细胞与诱导多能干细胞应用抗体推荐
19614
2026-04-14
【应用方向】抗体应用研究—细胞死亡
20259
2026-07-16
【应用方向】经典信号通路-JAK/STAT信号转导通路及抗体推荐
13169
2026-04-14
【应用方向】经典信号通路-MAPK/ERK信号转导通路及抗体推荐
13995
2026-04-14





